search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
II-VI INCREASES CAPACITY TO MEET MOLECULAR DIAGNOSTIC TESTING REQUIREMENTS


US optoelectronic component manufacturer II-VI increased its manufacturing capacity of components and subassemblies for molecular diagnostic testing systems. Specifically, the firm did so for those that underpin the polymerase chain reaction (PCR) testing platorms of its customers. An increase in deployment of PCR test


equipment at the healthcare point-of- service has been driving demand for the company’s subsystems, incorporating its thermoelectric and optical components. Tis allows rapid replication and identification of target genetic sequence. Te vendor is ramping up its global


manufacturing and supply chain to produce thermoelectric subassemblies in order to meet the recent and anticipated sustained surge in demand in the PCR system supply chain, which has largely been brought about by the spread of Covid-19. PCR systems have their challenges when


it comes to simultaneously applying a highly uniform and rapid rate of temperature change across the genetic sample to drive replication. II-VI is confident that


its thermoelectric products, which are designed in Dallas, Texas, and manufactured in Ho Chi Minh City, Vietnam, meet the stringent performance requirements and the reliability endurance of hundreds of thousands of rapid temperature cycles.ww Dr. Chuck Matera, chief executive officer,


II-VI Incorporated, said: ‘We are proud of all of our employees around the world for their tireless dedication to the life sciences ecosystems organised to overcome Covid-19.’


CABLELABS RELEASES SPEC FOR DOCSIS 4.0


Not-for-profit research and development lab CableLabs has released the DOCSIS 4.0 specification, including full duplex and extended spectrum capabilities. An important part of the suite of technologies that support the 10G platorm, DOCSIS 4.0 technology can achieve a downstream speed of up to 10Gb/s and an upstream speed of up to 6Gb/s.


Te new specification takes to heart the four pillars of the 10G platorm initiative: • •


Speed: multigigabit symmetric speeds raise the bar for consumer broadband;


Lower latency: this will provide a beter experience for consumers on applications such as online gaming and multimedia;





Increased security: security experts are constantly monitoring network threats and taking measures to increase the confidentiality, integrity and availability of communications; and


• Higher reliability: this must be planned into the network and DOCSIS technology includes methods to proactively identify and address network issues before consumers are aware of them.


In a statement, Doug Jones, principal architect at CableLabs, said: ‘With these speed increases, we intend to change the consumer broadband industry by ushering in a new era of application development. Although speed numbers are important, broadband is about so much more than speed: it’s about changing the way we collaborate to make the world a beter place. We have more devices, and our experiences increasingly rely on connectivity. As technology continues to advance, we don’t know what the next trend will be, but we do know that the internet will be central to whatever it is.’ Te next steps towards delivery of the specification include interoperability events and then


certification. www.fibre-systems.com @fibresystemsmag


FIBRE Optics


ACTIVE COMPONENTS


▪ Phase and Intensity Modulators ▪ RF Amplifi ers ▪ Bias Controllers


Issue 26 n Winter 2020 n www.lasercomponents.co.uk FiBRE SYSTEMS 5


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32